Zhejiang East Asia Pharmaceutical Co., Ltd. Class ASSE: 605177

"Zhejiang East-Asia Pharmaceutical Co., Ltd."Semi-annual Report for 2026

Aug 31, 2026 · Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang East Asia Pharmaceutical Co., Ltd. Class A

"Zhejiang East-Asia Pharmaceutical Co., Ltd."Announcement on Implementation of Repurchase and Cancellation of Certain Restricted Shares under the Equity Incentive PlanAug 24
"Zhejiang East-Asia Pharmaceutical Co., Ltd."Semi-annual Performance Forecast for 2026Jul 15
"Zhejiang East-Asia Pharmaceutical Co., Ltd."Announcement on Not Revising Downward the Conversion Price of "East-Asia Convertible Bonds"Jul 9
"Zhejiang East-Asia Pharmaceutical Co., Ltd."Indicative Announcement on "East-Asia Convertible Bonds" Expected to Meet Conditions for Revising Conversion PriceJul 2

All Zhejiang East Asia Pharmaceutical Co., Ltd. Class A news releases